ARCHIVES

Zaltrap Price Cut In Half Effective Immediately

This article is from The Cancer Letter archive.

Vol. 38 No. 42 | November 8, 2012

Download PDF Visit The Full Archive

Related Articles

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

ACS Funds $54 Million in Grants

June 28, 2002

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

In Brief: Sabin Leaves Frederick For So. Carolina; Georgia Worried Over Missing Out On Comprehensive Center

October 11, 1974

NCI Looking At CCOP Budgets To Determine How Many Will Be Funded; Some Top Scorers Identified

March 13, 1987